Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

PureTech to Present LYT-200 Phase 1b Results in MDS, AML at ESMO 2026

By Public Technologies
  • PureTech Health will present Phase 1b LYT-200 results at ESMO in Madrid on October 24, 2026.
  • Results showed encouraging clinical activity with favorable safety in heavily pretreated patients with relapsed/refractory high-risk myelodysplastic syndromes and acute myeloid leukemia.
  • Gallop Oncology plans to advance LYT-200 into the Phase 2 STRIDE-MDS trial for relapsed/refractory high-risk myelodysplastic syndromes following FDA discussions.
  • The drug received FDA Fast Track designation, supporting development in a population with limited treatment options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PureTech Health plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202610190200BIZWIRE_USPR_____20261018_BW068368) on October 19, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.